{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:27:57Z","timestamp":1771680477175,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Birth Defects Research"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Once a woman has had a fetus or infant affected with a neural tube defect (NTD), the risk of recurrence is approximately 3%. This risk can be significantly reduced by folic acid supplement consumption during the periconceptional period; however, this requires women at risk to be adequately informed about the appropriate dosage and timing of supplement intake before planning another pregnancy. As birth defects surveillance programs are tasked with identifying and documenting NTD\u2010affected pregnancies and births, they are in a unique position to support recurrence prevention activities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In 2015, we surveyed state and provincial birth defects surveillance programs to assess their NTD recurrence prevention activities. The online survey was sent to programs in 52 United States (U.S.) jurisdictions and all 13 provinces and territories in Canada. Findings were compared with a similar survey conducted in 2005 among U.S. programs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 2015, of the 44 U.S. and Canadian surveillance programs that responded, only 9 programs (7 U.S. and 2 Canadian) reported currently having activities specifically directed toward preventing NTD recurrence. Compared with a 2005 survey of U.S. programs, the number of U.S. programs working on NTD recurrence prevention decreased by almost 50% (from 13 to 7 programs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The number of birth defects surveillance programs with NTD recurrence prevention activities has decreased over the past decade due to a range of barriers, most notably a lack of resources. However, while some recurrence prevention activities require part\u2010time staff, other activities could be accomplished using minimal resources. Birth Defects Research (Part A) 106:875\u2013880, 2016.\u00a9 2016 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/bdra.23576","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T05:15:28Z","timestamp":1480310128000},"page":"875-880","source":"Crossref","is-referenced-by-count":4,"title":["Using state and provincial surveillance programs to reduce risk of recurrence of neural tube defects in the United States and Canada: A missed opportunity?"],"prefix":"10.1002","volume":"106","author":[{"given":"Timothy J.","family":"Flood","sequence":"first","affiliation":[{"name":"Arizona Birth Defects Monitoring Program Phoenix Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea M.","family":"Rienks","sequence":"additional","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities U.S. Centers for Disease Control and Prevention Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina L.","family":"Flores","sequence":"additional","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities U.S. Centers for Disease Control and Prevention Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara T.","family":"Mai","sequence":"additional","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities U.S. Centers for Disease Control and Prevention Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara K.","family":"Frohnert","sequence":"additional","affiliation":[{"name":"Birth Defects Monitoring and Analysis, Minnesota Department of Health St. Paul Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"College of Public Health University of South Florida Tampa Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Genetics University of Manitoba Winnipeg Manitoba Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell S.","family":"Kirby","sequence":"additional","affiliation":[{"name":"College of Public Health University of South Florida Tampa Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"CR262","article-title":"Physicians' knowledge and attitudes regarding periconceptional folic acid supplementation: a survey in Southern Israel","volume":"14","author":"Abu\u2010Hammad T","year":"2008","journal-title":"Med Sci Monit"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23100"},{"key":"e_1_2_7_4_1","first-page":"131","article-title":"Role of folic acid supplementation in prevention of neural tube defects: physicians yet unaware!","volume":"51","author":"Aggarwal A","year":"2010","journal-title":"J Prev Med Hyg"},{"key":"e_1_2_7_5_1","volume-title":"Neural tube defects. ACOG practice bulletin; no. 44. (Replaces Committee Opinion Number 252, March 2001) (Reaffirmed 2014)","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2003"},{"key":"e_1_2_7_6_1","first-page":"6","article-title":"Supplement use and other characteristics among pregnant women with a previous pregnancy affected by a neural tube defect \u2010 United States, 1997\u20102009","volume":"64","author":"Arth A","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37168"},{"key":"e_1_2_7_8_1","first-page":"513","article-title":"Use of folic acid for prevention of spina bifida and other neural tube defects \u2013 1983\u20101991","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"e_1_2_7_9_1","first-page":"001","article-title":"Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20619"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067103"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2004.10.006"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20394"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2008.07.008"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-200405000-00004"},{"key":"e_1_2_7_16_1","first-page":"6","volume-title":"Congenital anomalies in Canada 2013: a perinatal health surveillance report","author":"Lowry RB","year":"2013"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20075"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30057"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.90007"},{"key":"e_1_2_7_20_1","first-page":"63","volume-title":"Langman's medical embryology","author":"Sadler TW","year":"2012"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31821d4188"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00009"},{"key":"e_1_2_7_23_1","volume-title":"Preconception health: folic acid for the primary prevention of neural tube defects. A resource document for health professionals, 2002","author":"Allen MI","year":"2002"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30230-9"},{"key":"e_1_2_7_25_1","first-page":"199","article-title":"Update on prenatal care","volume":"89","author":"Zolotor AJ","year":"2014","journal-title":"Am Fam Physician"}],"container-title":["Birth Defects Research Part A: Clinical and Molecular Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.23576","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.23576","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdra.23576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T09:11:18Z","timestamp":1694596278000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.23576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1002\/bdra.23576"],"URL":"https:\/\/doi.org\/10.1002\/bdra.23576","archive":["Portico"],"relation":{},"ISSN":["1542-0752","1542-0760"],"issn-type":[{"value":"1542-0752","type":"print"},{"value":"1542-0760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}